EY Report Offers Advice For Medtech To Regain Its Pre-COVID Mojo
Executive Summary
The medtech industry’s overall revenue growth has slowed down in the last year along with a decline in M&A activity and venture spending in the sector, according to a new report from Ernst & Young. The authors proposed that to overcome those challenges, medtech should invest in a new health care system that is digitized, connected, and intelligent.
You may also be interested in...
Digital Health Roundup: HLTH, LSX, AdvaMed; FDA And Pre-Determined Change Control Plans
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with behavioral health experts on implementing AI solutions to help ease the administrative burden on clinicians as well as recent coverage from the LSX Congress USA and HLTH conferences. Reed Miller discusses findings of EY’s annual pulse of the medtech industry report and Hannah Daniel discusses FDA guidance on regulating AI/ML.
Minute Insight: Best Buy Will Sell Dexcom CGM
The retail giant will sell the Dexcom G7 continuous glucose monitoring system to eligible customers through a new online platform.
Ortho And Soft Tissue Robotics – Two Sides Of The Same Coin
Newcomers to the market have increased the number of options available to both soft tissue and orthopedic surgeons when selecting a robot. Despite the two disciplines' differences, the factors considered by surgeons when picking a system are relatively similar.